Breast Lift in Huntsville AL
Breast Lift in Huntsville section, includes general infrmation about Breast Lift Procedure, Breast Lift Huntsville Local News, Breast Lift Huntsville Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift huntsville (current)
huntsville Breast Reduction
huntsville Breast Implants
huntsville Implant Removal
huntsville Armpit Incision
More Huntsville info...
Plastic Surgery News...
- Diabetes is known to impair the cognitive health of people, but now scientists have identified one potential mechanism underlying these learning and memory problems.
- In a BMJ editorial, the authors from Imperial College write that despite evidence for the effectiveness of multitargeting kinase inhibitors in treating renal cell cancer, their availability in the UK has lagged behind that in the US because of the time taken to obtain regulatory approval. They note that renal cell cancer is a relatively unusual tumour that is diagnosed in about 2500 people each year in the UK and accounts for less than 1% of deaths from malignant disease. The evidence for bevacizumab, lapatinib, temsirolimus, sunitininb and sorafenib are then reviewed, along with a discussion about the possibility of combining these agents and using them with cytokines. They conclude “potentially there is real hope for patients with kidney cancer, but when will hope translate into the reality of treatment being available in the UK?” They point out that sunitinib was approved by the FDA in January 2007, in the same month that the trials were published; sunitinib and sorafenib were licensed by the European Medicines Agency in July 2006. They argue that patients in the UK should not have to wait another two years until NICE approves use of such treatments.